Status:

TERMINATED

Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption

Lead Sponsor:

Germans Trias i Pujol Hospital

Collaborating Sponsors:

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Conditions:

HIV Infections

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

To determine the influence of atorvastatin on plasma viral replication when the latter is given before and during highly active anti-retroviral therapy (HAART) in patients with HIV infection and viral...

Detailed Description

Recently, the inhibitory effect of the statins on the replication of the human immunodeficiency virus Type 1 (HIV-1) through two independent mechanisms of action has been described: the blockade of Rh...

Eligibility Criteria

Inclusion

  • Age \>= 18 years.
  • Patients with chronic infection by HIV-1 in stable highly active antiretroviral treatment (\>= 6 months).
  • Undetectable plasma viral load (\<50 copies/mL) in the last 3 determinations over the last 6 months.
  • CD4 \> 500 cells/mm\>=3 in the last two determinations.
  • Documented prior viral load at some time of \>15,000 copies/mL.
  • Women may not be of fertile age (defined as at least one year from menopause or undergoing any surgical sterilisation technique), or must undertake to use a barrier contraceptive method during the study.
  • Signature of the informed consent

Exclusion

  • CD4 nadir \<= 200 cells/mm3.
  • Background of infections or other AIDS-defining pathology.
  • Intercurrent infections in the last 6 months.
  • Creatine kinase (CK) \>= 500 U/L.
  • AST or ALT \>= 3 times higher than the upper limit of normality.
  • Treatment with others statins, fibrates, macrolides or fluconazole in the last 3 months.
  • Pregnancy or breastfeeding
  • Patients participating in another clinical trial

Key Trial Info

Start Date :

July 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2007

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT00355251

Start Date

July 1 2006

End Date

February 1 2007

Last Update

March 20 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Germans Trias i Pujol Hospital

Badalona, Barcelona, Spain, 08916